Financial News

Recent Quotes
My Watchlist
Indicators
Motherlode Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Alnylam Pharmaceuticals (NQ: ALNY )

168.41 USD UNCHANGED
Streaming Delayed Price Updated: 8:00 AM EST, Jan 20, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Alnylam Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9
...
46 47 Next >
First Week of September 17th Options Trading For Alnylam Pharmaceuticals (ALNY)
Investors in Alnylam Pharmaceuticals Inc (ALNY) saw new options become available this week, for the September 17th expiration. One of the key inputs that goes into the price an option buyer is willing... 
Tags Stocks
From Market News Video
The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags CELH APYX GTH
From Benzinga
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the ... 
Tags Market News Benzinga CRON
From Benzinga
Alnylam Launches “Alnylam P5x25” Strategy For Planned Transition To A Top Five Biotech In Market Capitalization Over Next Five Years
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced its new five-year strategy, “Alnylam P5x25,” which is focused on the company’s transition to a top-5 biotech (measured by... 
Tags Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
Notable Friday Option Activity: ALNY, LULU, UI
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Alnylam Pharmaceuticals Inc (ALNY), where a total volume of 4,762 contracts has... 
Tags Stocks
From Market News Video
Alnylam Pharmaceuticals Larger Than S&P 500 Component IDEX
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Alnylam Pharmaceuticals Inc (ALNY) was identified as having a larger market cap than the smaller end of the... 
Tags Stocks
From Market News Video
Analysts Forecast 10% Gains Ahead For The Holdings of BBH
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Interesting ALNY Put And Call Options For February 2021
Investors in Alnylam Pharmaceuticals Inc (ALNY) saw new options begin trading this week, for the February 2021 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the... 
Tags Stocks
From Market News Video
Should You Buy Sage Stock After the Biogen Investment?
Each company has suffered a clinical failure recently, but this team-up could do good things for both. 
Tags BIIB Market News ALNY
From Motley Fool
FDA Refuses to Approve Novartis' $9.7 Billion Cholesterol Drug for Now
The FDA's inability to inspect an overseas manufacturing facility is holding up an application for inclisiran. 
Tags NVS ALNY Market News
From Motley Fool
The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags SIOX ALNY CMRX
From Benzinga
Is The FDA Still Approving Drugs During the Pandemic?
Multiple drugmakers gained FDA approval last week. 
Tags REGN Market News LLY
From Motley Fool
Are These The Best Biotech Stocks To Watch Right Now? 3 To Consider As Pfizer’s Vaccine Rollout Begins
From Stockmarket.com
Reasons Alnylam Is a Top Biotech Stock to Buy Right Now
The company's rare disease treatments are a huge success and there will probably be a lot more of them. 
Tags SNY NVS ALNY
From Motley Fool
3 Reasons Alnylam Is a Top Biotech Stock to Buy Right Now
The company's rare disease treatments are a huge success and there will probably be a lot more of them. 
Tags SNY NVS ALNY
From Motley Fool
The Week Ahead In Biotech: Hematology Conference Gets Underway, Vanda And BioCryst Await FDA Decisions
Biotech stocks had a rather uneventful week, as the sector was seen mostly flatlining amid light trading volume ahead of the ... 
Tags FBIO ALLO APTO
From Benzinga
Attention Biotech Investors: Mark Your Calendar For Dec. PDUFA Dates
The U.S. Food and Drug Administration's approval machinery churned out a lot of disappointments in November. Most of the negative verdicts were tied to difficulties the agency had in inspecting... 
Tags Healthcare Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates
The U.S. Food and Drug Administration'sapproval machinery churned out a lot of disappointments in November. Most of the ... 
Tags ATNX BCRX SCPH
From Benzinga
Why These 3 Pharma Stocks Are Moving Today
Alnylam Pharmaceuticals (NASDAQ: ALNY) shares are trading higher on Tuesday after the company announced its OXLUMO injection has ... 
Tags Movers Market News why it's moving
From Benzinga
The Daily Biotech Pulse: Alnylam's Oxluma Snags Early FDA Approval, DBV Chief Scientific Officer To Depart, Decision Day For Liquidia
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags NVS LQDA CLPT
From Benzinga
The Math Shows FXH Can Go To $112
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ZSAN MSON NVCN
From Benzinga
The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings
Biotech stocks continued to sway to the tunes of the broader market in the week ended Oct. 30, which succumbed to geopolitical and ... 
Tags HZNP Penny Stocks TRXC
From Benzinga
Notable Monday Option Activity: AX, ALNY, GME
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Axos Financial Inc (AX), where a total volume of 1,220 contracts has been traded... 
Tags Stocks
From Market News Video
Alnylam Pharmaceuticals Breaks Below 200-Day Moving Average - Notable for ALNY
In trading on Friday, shares of Alnylam Pharmaceuticals Inc (ALNY) crossed below their 200 day moving average of $132.25, changing hands as low as $130.78 per share. Alnylam Pharmaceuticals Inc shares... 
Tags Stocks
From Market News Video
12 Healthcare Stocks Moving In Thursday's After-Market Session
Gainers Cassava Sciences (NASDAQ:SAVA) stock rose 20.61% to $10.65 during Thursday's after-market session. Today's trading ... 
Tags BCDA ECOR NXGN
From Benzinga
The Daily Biotech Pulse: FDA Vaccine Committee Meeting, Roche In $350M Deal for COVID-19 Treatment, Edwards Lifesciences Reports Q3 Beat
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ATXI HSDT FMTX
From Benzinga
The Week Ahead In Biotech: Spectrum Pharma FDA Decision, Biogen And Abbott Earnings, Cancer Conference
Biopharma stocks, which started the week on a firm footing, lost momentum mid-way through amid market-wide sell-off triggered by waning stimulus hopes. 
Tags Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
The Week Ahead In Biotech: Spectrum Pharma FDA Decision, Biogen And Abbott Earnings, Cancer Conference
Biopharma stocks, which started the week on a firmfooting, lost momentum mid-way through amid market-wide sell-off triggered by ... 
Tags FBIO DGX ALNY
From Benzinga
Vertex Tumbles As It Stops Testing On Protein Deficiency Treatment
Shares of Vertex plunged after hours Wednesday after the company announced it planned to stop testing on a drug designed to treat protein deficiencies. VRTX stock fell by double digits. 
From Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9
...
46 47 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback